I'm in your camp KayakerBC. Not interested in packaging both together for $1 billion. Two different companies with very different valuations. 

In Chic's post at 12:29pm yesterday he's talking about packaging both RVX and Zenith together for a billion and the comes back with all the things about RVX alone.

Maybe for RVX alone $1 billion but not both companies. Not with Zenith having apparent success with at least 2 of the 11 or 13 existing trials that are currently ongoing. I'll happily take the risk and wait out this current Zenith program. Look at the list of BP's involved in those trials, MRK, PFE, BMS, Lilly, Astella and others. No thanks, I'll wait for Zenith.

tada